FORTIS gained +1.9% on short buildup in futures
Fortis Healthcare closed Thursday's session at ₹785, up 1.95% from the previous close of ₹770, on a day the Nifty slipped 0.88%. The rise did not come from the open. The stock started 0.91% lower, traded down to a session low of ₹745.35, and then climbed through the afternoon to finish just under its day high of ₹786.4. By the close the live feed had it sitting at the day's high and 2.18% above VWAP, the volume-weighted average price paid for the stock across the session.
Turnover was heavy, although the pack gives two different readings of how heavy. The live signal flagged a volume spike of 6.2x, while the technicals block puts relative volume (today's volume against its usual level) at 5.05. Either way, far more shares changed hands than on a typical day.
The derivatives footprint points the other way, and it is dated. The F&O classification is short buildup, meaning fresh short futures positions were opened while the price fell, but it is stamped to the last close rather than to Thursday. That reading pairs a 3.76% rise in open interest with an 8.02% price decline. It describes positioning going into the session, and the pack carries no same-day open-interest figure to show whether any of those shorts were covered.
There is no institutional or insider trail to follow. The pack lists no bulk or block deals today, none in the past 30 days, and no insider filings in the past 60 days.
The bounce came after a steep slide. The stock was down 10.5% over the past week and 14.2% over the past month, and it sat 28.91% below its 52-week high and only 5.32% above its 52-week low. The 14-day RSI, a momentum gauge, stood at 24.7, a level usually described as oversold, and the price was below both its 50-day and 200-day moving averages. These figures may reflect the previous close rather than Thursday's finish. A MarketsMojo headline from 21 hours earlier said Fortis had formed a death cross, where the 50-day average drops below the 200-day, yet the pack's own death-cross flag reads false, so the two sources do not agree.
The most substantive news is three days old. According to reports from The Economic Times, The New Indian Express and Livemint, the Supreme Court allowed a forensic audit to go ahead, and Fortis was reported as saying it had no part in the dispute between Daiichi and the Singh brothers and expected the audit to clear it. The newer items, a Univest price-action review and an NDTV Profit viewer-question segment, report no new development.
The data shows no single obvious catalyst for Thursday's gain. What is visible is a sharp intraday recovery from below the previous close, on volume several times the normal level, against a falling index and after a week of heavy selling and a short-heavy futures setup. Whether short covering, bargain buying or something else drove it, the evidence here does not establish.
The numbers
- Last price ₹785.00, +1.95% on the day
- Day range ₹745.35 – ₹786.40
- Opening gap -0.91%
- NIFTY moved -0.88% the same session
Signals that fired
- Volume spike 6.2x
- At day's high
- vs NIFTY -0.88%
- Above VWAP +2.18%
- Short Buildup (last close)
F&O positioning
Futures classified as Short Buildup — open interest +3.8% with price -8.0% in the latest bhavcopy.
Technical context
Volume ran at 5.0× its 20-day average; rsi(14) sits at 25; price is 28.9% from the 52-week high.
Recent headlines
- Fortis Healthcare Ltd Forms Death Cross, Signalling Potential Bearish Trend — MarketsMojo (21h ago)
- Buy, Sell Or Hold: Fortis Healthcare, Tata Elxsi, Trent, Delhivery, Orient Electric — Ask Profit — NDTV Profit (21h ago)
- Fortis Healthcare Share Price Today: Price Action Review — Univest (1d ago)
- Fortis Healthcare shares in focus as Supreme Court allows forensic audit to proceed — The Economic Times (3d ago)
- Fortis says forensic audit will clear it of links to Singh brothers' dealings — The New Indian Express (3d ago)
- Fortis says it is ‘complete stranger’ to Daiichi-Singh Brothers dispute after SC allows forensic audit | Shares in focus — Livemint (3d ago)
- Fortis Healthcare Ltd (BOM:532843) (Q1 2027) Earnings Call Highlights: Revenue Surges 17. ... — GuruFocus.com (54d ago)
- India's Manipal Health to spend $414.4 million to expand capacity — Reuters (69d ago)
Sources
- Fortis Healthcare Ltd Forms Death Cross, Signalling Potential Bearish Trend — MarketsMojo
- Buy, Sell Or Hold: Fortis Healthcare, Tata Elxsi, Trent, Delhivery, Orient Electric — Ask Profit — NDTV Profit
- Fortis Healthcare Share Price Today: Price Action Review — Univest
- Fortis Healthcare shares in focus as Supreme Court allows forensic audit to proceed — The Economic Times
- Fortis says forensic audit will clear it of links to Singh brothers' dealings — The New Indian Express
- Fortis says it is ‘complete stranger’ to Daiichi-Singh Brothers dispute after SC allows forensic audit | Shares in focus — Livemint
- Fortis Healthcare Ltd (BOM:532843) (Q1 2027) Earnings Call Highlights: Revenue Surges 17. ... — GuruFocus.com
- India's Manipal Health to spend $414.4 million to expand capacity — Reuters
Keep digging
- FORTIS — full smart-money page: F&O positioning, deals, insider filings and option chain in one place.
- Today's screens: every stock matching the same setups (buildups, breakouts, volume shockers).
- Newsroom: the other stocks in play this session.